Unknown

Dataset Information

0

Synergistic inhibition of autophagy and neddylation pathways as a novel therapeutic approach for targeting liver cancer.


ABSTRACT: Liver cancer is the second-most frequent cause of cancer death in the world and is highly treatment resistant. We reported previously that inhibition of neddylation pathway with specific NAE inhibitor MLN4924, suppressed the malignant phenotypes of liver cancer. However, during the process, MLN4924 induces pro-survival autophagy as a mechanism of drug resistance. Here, we report that blockage of autophagy with clinically-available autophagy inhibitors (e.g. chloroquine) significantly enhanced the efficacy of MLN4924 on liver cancer cells by triggering apoptosis. Mechanistically, chloroquine enhanced MLN4924-induced up-regulation of pro-apoptotic proteins (e.g. NOXA) and down-regulation of anti-apoptotic proteins. Importantly, the down-regulation of NOXA expression via siRNA silencing substantially attenuated apoptosis of liver cancer cells. Further mechanistic studies revealed that blockage of autophagy augmented MLN4924-induced DNA damage and reactive oxygen species (ROS) generation. The elimination of DNA damage or blockage of ROS production significantly reduced the expression of NOXA, and thereby attenuated apoptosis and reduced growth inhibition of liver cancer cells. Moreover, blockage of autophagy enhanced the efficacy of MLN4924 in an orthotopic model of human liver cancer, with induction of NOXA and apoptosis in tumor tissues. These findings provide important preclinical evidence for clinical investigation of synergistic inhibition of neddylation and autophagy in liver cancer.

SUBMITTER: Chen P 

PROVIDER: S-EPMC4496198 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synergistic inhibition of autophagy and neddylation pathways as a novel therapeutic approach for targeting liver cancer.

Chen Ping P   Hu Tao T   Liang Yupei Y   Jiang Yanan Y   Pan Yongfu Y   Li Chunjie C   Zhang Ping P   Wei Dongping D   Li Pei P   Jeong Lak Shin LS   Chu Yiwei Y   Qi Hui H   Yang Meng M   Hoffman Robert M RM   Dong Ziming Z   Jia Lijun L  

Oncotarget 20150401 11


Liver cancer is the second-most frequent cause of cancer death in the world and is highly treatment resistant. We reported previously that inhibition of neddylation pathway with specific NAE inhibitor MLN4924, suppressed the malignant phenotypes of liver cancer. However, during the process, MLN4924 induces pro-survival autophagy as a mechanism of drug resistance. Here, we report that blockage of autophagy with clinically-available autophagy inhibitors (e.g. chloroquine) significantly enhanced th  ...[more]

Similar Datasets

| S-EPMC8028724 | biostudies-literature
| S-EPMC8380168 | biostudies-literature
| S-EPMC8113459 | biostudies-literature
| S-EPMC7463935 | biostudies-literature
| S-EPMC6496896 | biostudies-literature
| S-EPMC4241876 | biostudies-literature
| S-EPMC5161418 | biostudies-literature
| S-EPMC8467030 | biostudies-literature
2009-08-27 | E-GEOD-17525 | biostudies-arrayexpress
| S-EPMC7264106 | biostudies-literature